News room Service for journalists
Choose a category or subcategory
Latest News
-
Fidmi Medical Raises US$2 Million from B. Braun Melsungen AG
Read MoreFidmi Medical Ltd. (“Fidmi”), a portfolio company of The Trendlines Group (“Trendlines”) (SGX: 42T; OTCQX: TRNLY), announced that it received an investment of US$2 million from B. Braun Melsungen AG (“B. Braun”).
-
B. Braun is participating in the third edition of the High-Tech Founders Fund
Read MoreB. Braun Melsungen AG continues its commitment to promoting young, high-potential technology companies and is also participating in the third edition of the High-Tech Founders Fund (HTFF).
-
Personalized cancer therapy: B. Braun and CeGaT found joint venture CeCaVa
Read MoreMelsungen/Tübingen – The medical technology and pharmaceutical manufacturer B. Braun Melsungen AG and CeGaT GmbH in Tübingen have announced the creation of the joint venture CeCaVa GmbH & Co. KG.
Press contact
Christine Bossak
Head of Group Communications & Media Relations
B. Braun
Corporate Communications
Todiallee
Stadtwaldpark Haus 8/9
34212
Melsungen
Germany
Mechthild Claes
Senior Manager Corporate Communications
B. Braun
Corporate Communications
Todiallee
Stadtwaldpark Haus 8/9
34212
Melsungen
Germany
